Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 32 of Lineage Cell Therapeutics, Inc.'s SEC filings and found 4 warrant series, 2 ATM programs, 3 shelf registrations and 2 completed offerings on file for LCTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
LXEOLexeo Therapeutics, Inc. Common Stock
OCGNOcugen, Inc.
QTTBQ32 Bio Inc.
LRMRLarimar Therapeutics, Inc.
CAMPCAMP4 Therapeutics Corporation
FATEFate Therapeutics, Inc.
LYELLyell Immunopharma, Inc.
ABEOAbeona Therapeutics Inc.
CABACabaletta Bio, Inc.
IFRXInflaRx N.V. Common Stock
GLSIGreenwich LifeSciences, Inc.
BIOABioAge Labs Inc.
IMRXImmuneering Corporation
IPSCCentury Therapeutics, Inc.
FULCFulcrum Therapeutics, Inc.